FemTech medical device company Zero Candida Technologies has listed on the Frankfurt Stock Exchange (FSE) under the trading symbol “9L2”. The listing expands Zero Candida’s global...
The co-founder of fertility-focused supplement brand, WeNatal, has donated over $25,000 worth of products to her community after losing her own home in LA’s wildfires. Former...
A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated...
Innovative Birmingham-based nutrition firm Rem3dy Health has been recognised in the first-ever “Sunday Times 100 Tech: Britain’s fastest-growing private technology companies” list. The new rankings were...
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth...
Researchers have discovered that the loss of oestrogen and progesterone during menopause causes damage to bone cartilage and the cells that maintain it. However, they also...
Femtech World meets the founders of the FemAging Project, Denise Pines and Fard Johnmar, to hear more about their mission to harness innovation and address unmet...
The recent Women and Equalities Committee (WEC) report further highlighted how the UK public healthcare system is failing to meet the needs of women—now they want...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
By James Estrada, Planned Parenthood Federation of America (PPFA)
Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights. This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict...
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and...
The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation. We will be celebrating some...
Machine learning models can more quickly and affordably identify women with severe subjective cognitive decline during the menopause transition, effectively opening the door to better management...
By Gloria Kolb, Co-founder & CEO – Elitone
A new femtech-focussed accelerator has been launched, called, Alpha Startups Inno4Her, in South East Asia by Malaysia-based venture capital firm, 1337 Ventures. With the femtech market...
A new study underscores the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. A test based on the detection...
A treatment for breast cancer-related vasomotor symptoms (VMS) – known as hot flashes – has seen positive Phase 3 trial results in women with breast cancer or...
The second annual Femtech World Awards will celebrate the very best of women’s health innovation, recognising individuals and organisations helping to transform outcomes around the world....
Researchers are using AI to enhance detection accuracy and efficiency, paving the way for a transformation in cervical cancer screening. With the aid of deep learning...
